Cargando…
Pulmonary Surfactant Preserves Viability of Alveolar Type II Cells Exposed to Polymyxin B In Vitro
BACKGROUND: Exogenous surfactant derived from animal lungs is applied for treatment of surfactant deficiency. By means of its rapid spreading properties, it could transport pharmaceutical agents to the terminal air spaces. The antimicrobial peptide Polymyxin B (PxB) is used as a topical antibiotic f...
Autores principales: | Stichtenoth, Guido, Herting, Egbert, Rüdiger, Mario, Wemhöner, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631157/ https://www.ncbi.nlm.nih.gov/pubmed/23620808 http://dx.doi.org/10.1371/journal.pone.0062105 |
Ejemplares similares
-
Comparison of Polymyxin E and Polymyxin B as an Additive to Pulmonary Surfactant in Escherichia coli Pneumonia of Ventilated Neonatal Rabbits
por: Stichtenoth, Guido, et al.
Publicado: (2017) -
Effect of exogenous surfactants on viability and DNA synthesis in A549, immortalized mouse type II and isolated rat alveolar type II cells
por: Wemhöner, Andreas, et al.
Publicado: (2011) -
Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran
por: Ochs, Matthias, et al.
Publicado: (2006) -
Effects of Perfluorocarbons on surfactant exocytosis and membrane properties in isolated alveolar type II cells
por: Wemhöner, Andreas, et al.
Publicado: (2010) -
A randomised controlled trial in preterm infants comparing prophylactic with selective “less invasive surfactant administration” (pro.LISA)
por: Göpel, Wolfgang, et al.
Publicado: (2023)